Cision PR Newswire

Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy

NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has disease-modifying potential SINGAPORE, PARIS and PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, today announced that the first...

MINISFORUM Launches MS-S1 MAX-P495 with 192GB Unified Memory, Expanding Its Local AI Computing Strategy

SHENZHEN, China, Oct. 8, 2026 /PRNewswire/ -- As Artificial Intelligence (AI) evolves toward Super...

Dongpeng Highlights Sustainable Procurement at UN Global Compact Leaders Summit

Supplier capability building and circular materials connect sustainability requirements with opportunities for collaboration ...

Lufax Announces Poll Results of Extraordinary General Meeting

SHANGHAI, Oct. 8, 2026 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE:...

Euhomy Helps Keep This Summer Chilled With Launch of Rock Plus and Rock Pro Smart Ice Makers

New tabletop ice makers deliver crystal-clear square and sphere ice for elevated cocktails and premium home entertaining NEW YORK, May 29, 2026 /PRNewswire/...

DSC Holdings, AI Implementation Infrastructure for China’s Used-Car Industry, Files for Nasdaq Listing

NEW YORK, May 29, 2026 /PRNewswire/ -- The following report is from Deep Blue Finance:  DaSouChe Holdings Ltd. ("DSC") publicly filed its registration...

Hainan: A Microcosm of China’s Opening Up

HAIKOU, China, May 29, 2026 /PRNewswire/ -- A report from Hainan International Media Center: On December 18, 2025, Hainan, an island province just off...